186 related articles for article (PubMed ID: 18230899)
21. The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus.
Fujimoto WY
Am J Med; 2000 Apr; 108 Suppl 6a():9S-14S. PubMed ID: 10764845
[TBL] [Abstract][Full Text] [Related]
22. The islet circadian clock: entrainment mechanisms, function and role in glucose homeostasis.
Rakshit K; Qian J; Colwell CS; Matveyenko AV
Diabetes Obes Metab; 2015 Sep; 17 Suppl 1(0 1):115-22. PubMed ID: 26332976
[TBL] [Abstract][Full Text] [Related]
23. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
24. Olfactomedin 4 Deletion Improves Male Mouse Glucose Intolerance and Insulin Resistance Induced by a High-Fat Diet.
Liu W; Aerbajinai W; Li H; Liu Y; Gavrilova O; Jain S; Rodgers GP
Endocrinology; 2018 Sep; 159(9):3235-3244. PubMed ID: 30052841
[TBL] [Abstract][Full Text] [Related]
25. Obesity and type 2 diabetes: slow down!--Can metabolic deceleration protect the islet beta cell from excess nutrient-induced damage?
Andrikopoulos S
Mol Cell Endocrinol; 2010 Mar; 316(2):140-6. PubMed ID: 19815054
[TBL] [Abstract][Full Text] [Related]
26. Obesity-induced diabetes in mouse strains treated with gold thioglucose: a novel animal model for studying β-cell dysfunction.
Karasawa H; Takaishi K; Kumagae Y
Obesity (Silver Spring); 2011 Mar; 19(3):514-21. PubMed ID: 20706204
[TBL] [Abstract][Full Text] [Related]
27. In beta-cells, mitochondria integrate and generate metabolic signals controlling insulin secretion.
Maechler P; Carobbio S; Rubi B
Int J Biochem Cell Biol; 2006; 38(5-6):696-709. PubMed ID: 16443386
[TBL] [Abstract][Full Text] [Related]
28. [Comeback for the beta cells in the pathogenesis of diabetes].
Mulder H
Lakartidningen; 2010 Nov 10-16; 107(45):2796-800. PubMed ID: 21179864
[No Abstract] [Full Text] [Related]
29. Link between obesity and type 2 diabetes.
Golay A; Ybarra J
Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):649-63. PubMed ID: 16311223
[TBL] [Abstract][Full Text] [Related]
30. Type 2 diabetes mellitus: a disease of the governance of the glucose-insulin system: an experimental metabolic control analysis study.
Trombetta M; Boselli L; Cretti A; Calì A; Vettore M; Caruso B; Dorizzi R; Avogaro A; Muggeo M; Bonora E; Bonadonna RC
Nutr Metab Cardiovasc Dis; 2013 Jan; 23(1):23-30. PubMed ID: 21937205
[TBL] [Abstract][Full Text] [Related]
31. Impaired beta cell glucose sensitivity and whole-body insulin sensitivity as predictors of hyperglycaemia in non-diabetic subjects.
Walker M; Mari A; Jayapaul MK; Bennett SM; Ferrannini E
Diabetologia; 2005 Dec; 48(12):2470-6. PubMed ID: 16261308
[TBL] [Abstract][Full Text] [Related]
32. Beta-cell failure as a complication of diabetes.
Chang-Chen KJ; Mullur R; Bernal-Mizrachi E
Rev Endocr Metab Disord; 2008 Dec; 9(4):329-43. PubMed ID: 18777097
[TBL] [Abstract][Full Text] [Related]
33. Fatty acid-induced mitochondrial uncoupling in adipocytes as a key protective factor against insulin resistance and beta cell dysfunction: a new concept in the pathogenesis of obesity-associated type 2 diabetes mellitus.
Maassen JA; Romijn JA; Heine RJ
Diabetologia; 2007 Oct; 50(10):2036-41. PubMed ID: 17712547
[TBL] [Abstract][Full Text] [Related]
34. Hepatic glucose metabolism and insulin resistance in NIDDM and obesity.
Barrett EJ; Liu Z
Baillieres Clin Endocrinol Metab; 1993 Oct; 7(4):875-901. PubMed ID: 8304916
[No Abstract] [Full Text] [Related]
35. Characterization of beta-cell function of pancreatic islets isolated from bank voles developing glucose intolerance/diabetes: an animal model showing features of both type 1 and type 2 diabetes mellitus, and a possible role of the Ljungan virus.
Blixt M; Niklasson B; Sandler S
Gen Comp Endocrinol; 2007; 154(1-3):41-7. PubMed ID: 17686482
[TBL] [Abstract][Full Text] [Related]
36. [Pathogenic mechanism of type 2 diabetes mellitus from impaired glucose tolerance/borderline type and its reversibility].
Yoshimoto K; Ozawa S; Ishida H
Nihon Rinsho; 2005 Feb; 63 Suppl 2():95-9. PubMed ID: 15779352
[No Abstract] [Full Text] [Related]
37. The mechanisms linking adiposopathy to type 2 diabetes.
Yang J; Kang J; Guan Y
Front Med; 2013 Dec; 7(4):433-44. PubMed ID: 24085616
[TBL] [Abstract][Full Text] [Related]
38. Enhanced glucose-induced intracellular signaling promotes insulin hypersecretion: pancreatic beta-cell functional adaptations in a model of genetic obesity and prediabetes.
Irles E; Ñeco P; Lluesma M; Villar-Pazos S; Santos-Silva JC; Vettorazzi JF; Alonso-Magdalena P; Carneiro EM; Boschero AC; Nadal Á; Quesada I
Mol Cell Endocrinol; 2015 Mar; 404():46-55. PubMed ID: 25633666
[TBL] [Abstract][Full Text] [Related]
39. Fate of the beta-cell in the pathophysiology of type 2 diabetes.
Campbell RK
J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S10-5. PubMed ID: 19801360
[TBL] [Abstract][Full Text] [Related]
40. Metabolic signaling in fuel-induced insulin secretion.
Prentki M; Matschinsky FM; Madiraju SR
Cell Metab; 2013 Aug; 18(2):162-85. PubMed ID: 23791483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]